This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX7QV, is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $7,199.26 and a completion date of December 27, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside.
AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 3/27/25, 9:59 AM